For example, in osteosarcoma tissues and DOX-resistant osteosarcoma cells, miR-198 targets and upregulates ABCB1 expression, increasing the sensitivity of osteosarcoma cells to doxorubicin and thereby enhancing drug efficacy [131]. Here, ABCB1 is linked to osteosarcoma.